Slit2-Robo4 receptor responses inhibit ANDV directed permeability of human lung microvascular endothelial cells

Antiviral Research

Volumn 99, Issue 2, 2013, Pages 108-112

  Gorbunova, Elena E ^a   Gavrilovskaya, Irina N ^a   Mackow, Erich R ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Hantavirus; Human endothelial cells; Inhibition; Permeability; Slit2

Indexed keywords

ROBO4 RECEPTOR; ROUNDABOUT RECEPTOR; SLIT2 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANDES VIRUS; ARTICLE; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; HANTAVIRUS; HANTAVIRUS INFECTION; HUMAN; HUMAN CELL; LUNG EDEMA; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PULMONARY MICROVASCULAR ENDOTHELIAL CELL; RECEPTOR BINDING; UMBILICAL VEIN ENDOTHELIAL CELL;

HANTAVIRUS; HUMAN ENDOTHELIAL CELLS; INHIBITION; PERMEABILITY; SLIT2;

ADHERENS JUNCTIONS; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HANTAAN VIRUS; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG; MICROVESSELS; NERVE TISSUE PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RNA INTERFERENCE; RNA, SMALL INTERFERING;

ANDES VIRUS; HANTAAN VIRUS; HANTAVIRUS;

EID: 84878687560     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.05.004     Document Type: Article

References (51)

1. Acevedo L.M., Weis S.M., Cheresh D.A. Robo4 counteracts VEGF signaling. Nat. Med. 2008, 14:372-373.
2. Berger M.M., Hesse C., Dehnert C., Siedler H., Kleinbongard P., Bardenheuer H.J., Kelm M., Bartsch P., Haefeli W.E. Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema. Am. J. Respir. Crit. Care Med. 2005, 172:763-767.
3. Bustamante E.A., Levy H., Simpson S.Q. Pleural fluid characteristics in hantavirus pulmonary syndrome. Chest 1997, 112:1133-1136.
4. Chang B., Crowley M., Campen M., Koster F. Hantavirus cardiopulmonary syndrome. Semin. Respir. Crit. Care Med. 2007, 28:193-200.
5. Dehler M., Zessin E., Bartsch P., Mairbaurl H. Hypoxia causes permeability oedema in the constant-pressure perfused rat lung. Eur. Respir. J. 2006, 27:600-606.
6. Dickinson R.E., Duncan W.C. The SLIT-ROBO pathway: a regulator of cell function with implications for the reproductive system. Reproduction 2011, 139:697-704.
7. Duchin J.S., Koster F.T., Peters C.J., Simpson G.L., Tempest B., Zaki S.R., Ksiazek T.G., Rollin P.E., Nichol S., Umland E.T., Moolenaar R.L., Reef S.E., Nolte K.B., Gallaher M.M., Butler J.C., Breiman R.F. Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group [see comments]. N. Engl. J. Med. 1994, 330:949-955. H.S. Group.
8. Dvorak H.F. Discovery of vascular permeability factor (VPF). Exp. Cell Res. 2006, 312:522-526.
9. Dvorak H.F., Sioussat T.M., Brown L.F., Berse B., Nagy J.A., Sotrel A., Manseau E.J., Van de Water L., Senger D.R. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J. Exp. Med. 1991, 174:1275-1278.
10. Enria D., Padula P., Segura E.L., Pini N., Edelstein A., Posse C.R., Weissenbacher M.C. Hantavirus pulmonary syndrome in Argentina. Possibility of person to person transmission. Medicina 1996, 56:709-711.
11. Galeno H., Mora J., Villagra E., Fernandez J., Hernandez J., Mertz G.J., Ramirez E. First human isolate of Hantavirus (Andes virus) in the Americas. Emerg. Infect. Dis. 2002, 8:657-661.
12. Gavard J., Gutkind J.S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 2006, 8:1223-1234.
13. Gavard J., Patel V., Gutkind J.S. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev. Cell 2008, 14:25-36.
14. Gavrilovskaya I.N., Shepley M., Shaw R., Ginsberg M.H., Mackow E.R. Beta3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. USA 1998, 95:7074-7079.
15. Gavrilovskaya I.N., Gorbunova E.E., Mackow N.A., Mackow E.R. Hantaviruses direct endothelial cell permeability by sensitizing cells to the vascular permeability factor VEGF, while angiopoietin 1 and sphingosine 1-phosphate inhibit hantavirus-directed permeability. J. Virol. 2008, 82:5797-5806.
16. Gavrilovskaya I.N., Gorbunova E.E., Mackow E.R. Pathogenic hantaviruses direct the adherence of quiescent platelets to infected endothelial cells. J. Virol. 2010, 84:4832-4839.
17. Gavrilovskaya I., Gorbunova E., Koster F., Mackow E. Elevated VEGF levels in pulmonary edema fluid and PBMCs from patients with acute hantavirus pulmonary syndrome. Adv. Virol. 2012, 2012:674360.
18. Gavrilovskaya I.N., Gorbunova E.E., Mackow E.R. Andes virus infection of lymphatic endothelial cells causes giant cell and enhanced permeability responses that are rapamycin and vascular endothelial growth factor C sensitive. J. Virol. 2012, 86:8765-8772.
19. Geimonen E., Neff S., Raymond T., Kocer S.S., Gavrilovskaya I.N., Mackow E.R. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc. Natl. Acad. Sci. USA 2002, 99:13837-13842.
20. Gorbunova E., Gavrilovskaya I.N., Mackow E.R. Pathogenic hantaviruses Andes virus and Hantaan virus induce adherens junction disassembly by directing vascular endothelial cadherin internalization in human endothelial cells. J. Virol. 2010, 84:7405-7411.
21. Gorbunova E.E., Gavrilovskaya I.N., Pepini T., Mackow E.R. VEGFR2 and Src kinase inhibitors suppress ANDV induced endothelial cell permeability. J. Virol. 2011, 85:2296-2303.
22. Hallin G.W., Simpson S.Q., Crowell R.E., James D.S., Koster F.T., Mertz G.J., Levy H. Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit. Care Med. 1996, 24:252-258.
23. Hopkins S.R., Garg J., Bolar D.S., Balouch J., Levin D.L. Pulmonary blood flow heterogeneity during hypoxia and high-altitude pulmonary edema. Am. J. Respir. Crit. Care Med. 2005, 171:83-87.
24. Jones C.A., Nishiya N., London N.R., Zhu W., Sorensen L.K., Chan A.C., Lim C.J., Chen H., Zhang Q., Schultz P.G., Hayallah A.M., Thomas K.R., Famulok M., Zhang K., Ginsberg M.H., Li D.Y. Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity. Nat. Cell Biol. 2009, 11:1325-1331.
25. Jonsson C.B., Hooper J., Mertz G. Treatment of hantavirus pulmonary syndrome. Antiviral Res. 2008, 78:162-169.
26. Kaur S., Samant G.V., Pramanik K., Loscombe P.W., Pendrak M.L., Roberts D.D., Ramchandran R. Silencing of directional migration in roundabout4 knockdown endothelial cells. BMC Cell Biol. 2008, 9:61.
27. Koch A.W., Mathivet T., Larrivee B., Tong R.K., Kowalski J., Pibouin-Fragner L., Bouvree K., Stawicki S., Nicholes K., Rathore N., Scales S.J., Luis E., del Toro R., Freitas C., Breant C., Michaud A., Corvol P., Thomas J.L., Wu Y., Peale F., Watts R.J., Tessier-Lavigne M., Bagri A., Eichmann A. Robo4 maintains vessel integrity and inhibits angiogenesis by interacting with UNC5B. Dev. Cell 2011, 20:33-46.
28. Kosmidou I., Karmpaliotis D., Kirtane A.J., Barron H.V., Gibson C.M. Vascular endothelial growth factors in pulmonary edema: an update. J. Thromb. Thrombolysis 2008, 25:259-264.
29. Koster F., Mackow E. Pathogenesis of the hantavirus pulmonary syndrome. Future Virol. 2012, 7:41-51.
30. Koster F., Foucar K., Hjelle B., Scott A., Chong Y.Y., Larson R., McCabe M. Rapid presumptive diagnosis of hantavirus cardiopulmonary syndrome by peripheral blood smear review. Am. J. Clin. Pathol. 2001, 116:665-672.
31. Levis S., Rowe J., Morzunov S., Enria D., St.Jeor S. New hantaviruses causing hantavirus pulmonary syndrome in central America. Lancet 1997, 349:998-999.
32. London N.R., Li D.Y. Robo4-dependent Slit signaling stabilizes the vasculature during pathologic angiogenesis and cytokine storm. Curr. Opin. Hematol. 2011, 18:186-190.
33. London N.R., Smith M.C., Li D.Y. Emerging mechanisms of vascular stabilization. J. Thromb. Haemost. 2009, 7(Suppl. 1):57-60.
34. Lopez N., Padula P., Rossi C., Lazaro M.E., Franze-Fernandez M.T. Genetic identification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 1996, 220:223-226.
35. Mackow E.R., Gavrilovskaya I.N. Hantavirus regulation of endothelial cell functions. Thromb. Haemost. 2009, 102:1030-1041.
36. Macneil A., Nichol S.T., Spiropoulou C.F. Hantavirus pulmonary syndrome. Virus Res. 2011, 162:138-147.
37. Manalo D.J., Rowan A., Lavoie T., Natarajan L., Kelly B.D., Ye S.Q., Garcia J.G., Semenza G.L. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005, 105:659-669.
38. Marlow R., Binnewies M., Sorensen L.K., Monica S.D., Strickland P., Forsberg E.C., Li D.Y., Hinck L. Vascular Robo4 restricts proangiogenic VEGF signaling in breast. Proc. Natl. Acad. Sci. USA 2010, 107:10520-10525.
39. Nagy J.A., Dvorak A.M., Dvorak H.F. Vascular hyperpermeability, angiogenesis, and stroma generation. Cold Spring Harb. Perspect. Med. 2012, 2:a006544.
40. Nolte K.B., Feddersen R.M., Foucar K., Zaki S.R., Koster F.T., Madar D., Merlin T.L., McFeeley P.J., Umland E.T., Zumwalt R.E. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum. Pathol. 1995, 26:110-120.
41. Padula P.J., Edelstein A., Miguel S.D., Lopez N.M., Rossi C.M., Rabinovich R.D. Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virology 1998, 241:323-330.
42. Pepini T., Gorbunova E.E., Gavrilovskaya I., Mackow J.E., Mackow E.R. Andes virus regulation of cellular microRNAs contributes to hantavirus induced endothelial cell permeability. J. Virol. 2010, 84:11929-11936.
43. Raymond T., Gorbunova E., Gavrilovskaya I.N., Mackow E.R. Pathogenic hantaviruses bind plexin-semaphorin-integrin domains present at the apex of inactive, bent alphavbeta3 integrin conformers. Proc. Natl. Acad. Sci. USA 2005, 102:1163-1168.
44. Robinson S.D., Reynolds L.E., Wyder L., Hicklin D.J., Hodivala-Dilke K.M. Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability. Arterioscler. Thromb. Vasc. Biol. 2004, 24:2108-2114.
45. Schmaljohn C., Hjelle B. Hantaviruses: a global disease problem. Emerg. Infect. Dis. 1997, 3:95-104.
46. Sheldon H., Andre M., Legg J.A., Heal P., Herbert J.M., Sainson R., Sharma A.S., Kitajewski J.K., Heath V.L., Bicknell R. Active involvement of Robo1 and Robo4 in filopodia formation and endothelial cell motility mediated via WASP and other actin nucleation-promoting factors. FASEB J. 2009, 23:513-522.
47. Shrivastava-Ranjan P., Rollin P.E., Spiropoulou C.F. Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-cadherin. J. Virol. 2010, 84:11227-11234.
48. Stenmark K.R., Fagan K.A., Frid M.G. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ. Res. 2006, 99:675-691.
49. Tang N., Wang L., Esko J., Giordano F.J., Huang Y., Gerber H.P., Ferrara N., Johnson R.S. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 2004, 6:485-495.
50. Xu M., Waters C.L., Hu C., Wysolmerski R.B., Vincent P.A., Minnear F.L. Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase. Am. J. Physiol. Cell Physiol. 2007, 293:C1309-C1318.
51. Zaki S., Greer P., Coffield L., Goldsmith C., Nolte K., Foucar K., Feddersen R., Zumwalt R., Miller G., Rollin P., Ksiazek T., Nichol S., Peters C. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am. J. Pathol. 1995, 146:552-579.